CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Lifecore Biomedical

Advertisement

Solstice
News

Speaker line-up announced for Medical Device Regulation workshop

Experts from European Commission set to advise EU regulatory affairs professionals on new regulation The Regulatory Affairs Professionals Society (RAPS) has announce...
Continue Reading →
News

Dance Biopharm and Phillips-Medisize Enter into Joint Development Agreement for Advanced Inhaled Insulin Delivery

Dance Biopharm Holdings Inc. (“Dance”), a privately-held biotechnology company focused on the development of Dance 501, a proprietary ‘soft-mist’ inhaled insulin pro...
Continue Reading →
News

Phillips-Medisize and Molex at Compamed: One Team, Infinite Possibilities

Phillips-Medisize, a Molex company, will be exhibiting at K39 in hall 8a during COMPAMED 2017. COMPAMED takes place simultaneously with the Medica exhibition on Nove...
Continue Reading →
News

Gerresheimer Medical Systems at Compamed 2017: From usability engineering through to a CE-marked product

As a full-service provider, Gerresheimer Medical Systems will be attending the Compamed trade fair in Düsseldorf from November 13 to 16, with an exhibit at booth P33...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026